Health Care Notes: VUMC to launch Long COVID drug trial
Also: Tennessee Oncology lands rural health grant; HCA introduces outpatient cancer treatment option
Stay updated with breaking news from Cellular Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Also: Tennessee Oncology lands rural health grant; HCA introduces outpatient cancer treatment option
Ruxolitinib and belumosudil demonstrated a beneficial ORR, indicating synergistic effects in targeting multiple inflammatory pathways in chronic GVHD.
The University of Texas MD Anderson Cancer Center today was awarded 16 grants totaling over $25.5 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of cancer screening, early detection and prevention programs, faculty recruitment, and groundbreaking cancer research across all areas of the institution.
Brexu-cel showed efficacy in eliciting both CNS and systemic responses in patients with relapsed/refractory B-cell acute lymphoblastic leukemia.
HCA Healthcare, Inc. , one of the nation’s leading healthcare providers, today announced that the Sarah Cannon Cancer Institute of HCA Healthcare has successfully established an integrated...